To describe the rationale, methods and 6 year experience with a real-world, single-surgeon voluntary registry for female pelvic reconstructive and incontinence procedures and the feasibility of capturing post-operative outcomes.
OBJECTIVES:
To describe the rationale, methods and 6 year experience with a real-world, single-surgeon voluntary registry for female pelvic reconstructive and incontinence procedures and the feasibility of capturing post-operative outcomes.
MATERIALS AND METHODS:
The primary goal of creating this registry was to establish the feasibility of a voluntary, surgeon-initiated prospective data capture to facilitate quality assessment for urogynecologic procedures. Secondary aims included identifying quality improvement opportunities based on the goal of 100% surgical case reporting. Data captured included baseline demographics, preoperative and postoperative symptoms using validated questionnaires (Pelvic Floor Distress Inventory [PFDI] and Pelvic Floor Impact Questionnaire [PFIQ] ) and physical examination findings (Pelvic Organ Prolapse Quantification [POP-Q]), surgical procedures and intra-and post-operative complications. The PRISM Registry sought to capture the surgical procedure and follow-up intervals according to the surgeon's standard practice without modification including 6 weeks and 6, 12, 24, and 36 months after surgery in a largely rural 150 mile radius catchment area. RESULTS: Between December 2010 and May 2016, surgical and clinical data for 843 individual cases from a single surgeon was captured within the PRISM Registry with IRB approval, comprising 100% surgical case capture. Cases included 113 hysterectomies, 1252 prolapse repairs (including 347 suspensions), 379 anti-incontinence procedures, 19 fistulas, 7 neo-vaginas, and 122 mesh excisions, totaling 2062 procedures on 652 unique patients. In some cases (n ¼ 444), patients were not asked to participate in long-term follow-up and thus were excluded from analysis (Figure 1) . The remaining 399 patients participated in post-operative visits with attendance of 95% at 6 weeks, 64% at 6 months, 51% at 12 months, 39% at 24 months, and 22% at 36 months. Of the patients who reported any positive prolapse or incontinence symptom on the PFDI, PFIQ, or POP-Q at 6 months (n ¼ 16), 68% returned for their 12 months surveillance visit (p ¼ 0.04). No clinical predictors for visit adherence were found at any other time point. Periodic internal auditing identified 6 transobturator sling erosions (7%) and in 2014 a different device and resident teaching methodology was selected with no subsequent sling erosions (n ¼ 42). CONCLUSION: The PRISM Registry captures urogynecologic procedures for the purposes of quality improvement. PRISM demonstrates that 100% case capture is feasible and fruitful for the highly motivated surgeon, although adequate long-term follow-up without structured patient incentives may be limited, outside a metropolitan area. Additional research is needed to better understand the role of surgical registries for quality improvement and to develop patientcentered strategies to increase long-term follow-up.
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